Companies:

 

Articles:

 

Stock summary

Companies:

 

Argenica Therapeutics Limited (ASX: AGN)

 
Service provided by WebLinkIR

Company videos

Company news

Cover Image for Argenica Therapeutics gains ethics approval for phase 1 clinical trial of stroke drug ARG-007

Argenica Therapeutics gains ethics approval for phase 1 clinical trial of stroke drug ARG-007

Cover Image for Argenica Therapeutics reports positive findings from peer-reviewed study of stroke drug ARG-007

Argenica Therapeutics reports positive findings from peer-reviewed study of stroke drug ARG-007

Cover Image for Argenica Therapeutics tops up bank balance with $5.5m placement to advance ARG-007 in other neurological conditions

Argenica Therapeutics tops up bank balance with $5.5m placement to advance ARG-007 in other neurological conditions

Cover Image for Argenica Therapeutics moves closer to phase 1 in-human trials of ARG-007 for stroke

Argenica Therapeutics moves closer to phase 1 in-human trials of ARG-007 for stroke